Published in J Clin Exp Neuropsychol on November 26, 2008
Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients. PLoS One (2015) 0.75
The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
What is "special" about face perception? Psychol Rev (1998) 4.46
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology (2006) 3.69
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol (2003) 3.47
Hemispheric specialization in human dorsal frontal cortex and medial temporal lobe for verbal and nonverbal memory encoding. Neuron (1998) 2.85
The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med (1987) 2.58
Face encoding and recognition in the human brain. Proc Natl Acad Sci U S A (1996) 2.31
Trajectory of mild cognitive impairment onset. J Int Neuropsychol Soc (2008) 2.13
Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention program. Dement Geriatr Cogn Disord (2006) 1.57
Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Arch Neurol (1986) 1.54
Face memory impairments in patients with frontal lobe damage. Neurology (2001) 1.43
The contribution of recollection and familiarity to recognition memory: a study of the effects of test format and aging. Neuropsychology (2003) 1.36
Natural history of cognitive decline in the old old. Neurology (2003) 1.31
The joint WAIS-III and WMS-III factor structure: development and cross-validation of a six-factor model of cognitive functioning. Psychol Assess (2003) 1.27
Amnesia and recognition memory: a re-analysis of psychometric data. Neuropsychologia (1996) 1.24
Confirmatory factor analysis of the Wechsler Memory Scale-III. J Clin Exp Neuropsychol (1999) 1.18
The effects of encoding task on age-related differences in the functional neuroanatomy of face memory. Psychol Aging (2002) 1.13
Episodic and semantic memory in mild cognitive impairment. Neuropsychologia (2005) 1.03
Redefining the factor structure of the Wechsler Memory Scale-III: confirmatory factor analysis with cross-validation. J Clin Exp Neuropsychol (2002) 0.98
Interobserver disagreements on clinical dementia rating assessment: interpretation and implications for training. Alzheimer Dis Assoc Disord (2001) 0.97
Examining the right temporal lobe's role in nonverbal memory. Brain Cogn (1997) 0.95
Differing profiles of face and scene discrimination deficits in semantic dementia and Alzheimer's disease. Neuropsychologia (2007) 0.92
Facial recognition memory deficits in normal aging and senile dementia. J Gerontol (1980) 0.91
WMS-III performance in patients with temporal lobe epilepsy: group differences and individual classification. J Int Neuropsychol Soc (2001) 0.91
Parsing the recognition memory components of the WMS-III face memory subtest: normative data and clinical findings in dementia groups. J Clin Exp Neuropsychol (2004) 0.89
Confirmatory factor analysis of the WMS-III in patients with temporal lobe epilepsy. Psychol Assess (2003) 0.88
WMS-III performance in epilepsy patients following temporal lobectomy. J Int Neuropsychol Soc (2004) 0.86
Facial recognition memory in dementia. Cortex (1982) 0.80
Recognition memory in Alzheimer's disease. Neurobiol Aging (1985) 0.79
A new look at the WMS-III: new research to guide clinical practice. J Clin Exp Neuropsychol (2004) 0.79
Recognition memory for words and faces in primary degenerative dementia of the Alzheimer type and normal old age. J Clin Exp Neuropsychol (1990) 0.79
Face memory and its disorders. Curr Neurol Neurosci Rep (2003) 0.78
About the power for detecting severe impairment in older adults with the Faces test from Wechsler Memory Scale-III: simply guess and save face. J Clin Exp Neuropsychol (2003) 0.77
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol (2006) 2.79
Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol (2002) 2.70
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
Trajectory of mild cognitive impairment onset. J Int Neuropsychol Soc (2008) 2.13
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Unobtrusive assessment of activity patterns associated with mild cognitive impairment. Alzheimers Dement (2008) 1.95
Uric acid as a CNS antioxidant. J Alzheimers Dis (2010) 1.93
Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann Neurol (2002) 1.79
An electronic pillbox for continuous monitoring of medication adherence. Conf Proc IEEE Eng Med Biol Soc (2006) 1.72
Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology (2012) 1.66
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke (2004) 1.63
Cognitive impairment risk: white matter hyperintensity progression matters. Neurology (2009) 1.46
APOE ε4 increases risk for dementia in pure synucleinopathies. JAMA Neurol (2013) 1.41
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis (2008) 1.40
Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J Alzheimers Dis (2005) 1.39
Parkinson's disease is associated with hippocampal atrophy. Mov Disord (2003) 1.37
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One (2011) 1.32
Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology (2013) 1.29
Medication adherence in healthy elders: small cognitive changes make a big difference. J Aging Health (2009) 1.26
Biomarkers for cognitive impairment and dementia in elderly people. Lancet Neurol (2008) 1.25
Physical activity and the risk of dementia in oldest old. J Aging Health (2007) 1.22
Greater orbital prefrontal volume selectively predicts worse working memory performance in older adults. Cereb Cortex (2002) 1.17
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging (2010) 1.16
Symptoms of sleep disturbance in persons with Alzheimer's disease and normal elderly. J Sleep Res (2005) 1.13
Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. J Alzheimers Dis (2004) 1.07
A study of medication-taking and unobtrusive, intelligent reminding. Telemed J E Health (2009) 1.07
Neuropathologic basis of age-associated brain atrophy. JAMA Neurol (2013) 1.05
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol (2011) 1.01
Trends in the prevalence of dementia in Japan. Int J Alzheimers Dis (2012) 1.01
Patterns of dietary supplement usage in demographically diverse older people. Altern Ther Health Med (2005) 1.01
Computer-related self-efficacy and anxiety in older adults with and without mild cognitive impairment. Alzheimers Dement (2012) 0.99
Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J Alzheimers Dis (2009) 0.98
Executive function predicts risk of falls in older adults without balance impairment. BMC Geriatr (2011) 0.98
Magnetic resonance approaches to brain aging and Alzheimer disease-associated neuropathology. Top Magn Reson Imaging (2005) 0.95
Unobtrusive in-home detection of time spent out-of-home with applications to loneliness and physical activity. IEEE J Biomed Health Inform (2014) 0.95
Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease. Curr Gerontol Geriatr Res (2012) 0.94
Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease. J Neuropathol Exp Neurol (2010) 0.93
Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. J Neurosci Res (2005) 0.93
Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. Mol Cell Proteomics (2011) 0.92
Estimation of rest-activity patterns using motion sensors. Conf Proc IEEE Eng Med Biol Soc (2010) 0.91
ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiol Aging (2012) 0.91
Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study. J Gerontol A Biol Sci Med Sci (2010) 0.91
Associations between observed in-home behaviors and self-reported low mood in community-dwelling older adults. J Am Geriatr Soc (2014) 0.89
Sleep habits in mild cognitive impairment. Alzheimer Dis Assoc Disord (2014) 0.89
Neural networks for longitudinal studies in Alzheimer's disease. Artif Intell Med (2006) 0.89
Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease. Dement Geriatr Cogn Disord (2005) 0.88
Translational gene mapping of cognitive decline. Neurobiol Aging (2006) 0.87
Characterizing sleep problems in persons with Alzheimer's disease and normal elderly. J Sleep Res (2006) 0.85
Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2012) 0.84
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol (2015) 0.84
SVM to detect the presence of visitors in a smart home environment. Conf Proc IEEE Eng Med Biol Soc (2012) 0.82
Review of selected databases of longitudinal aging studies. Alzheimers Dement (2012) 0.82
Reactions to a remote-controlled video-communication robot in seniors' homes: a pilot study of feasibility and acceptance. Telemed J E Health (2012) 0.81
Embedded Online Questionnaire Measures Are Sensitive to Identifying Mild Cognitive Impairment. Alzheimer Dis Assoc Disord (2016) 0.79
Social Markers of Mild Cognitive Impairment: Proportion of Word Counts in Free Conversational Speech. Curr Alzheimer Res (2015) 0.79
Characteristics associated with willingness to participate in a randomized controlled behavioral clinical trial using home-based personal computers and a webcam. Trials (2014) 0.79
Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease. J Alzheimers Dis (2005) 0.78
Healthy brain aging. Arch Neurol (2002) 0.77
Social activity decreases risk of placement in a long-term care facility for a prospective sample of community-dwelling older adults. Res Gerontol Nurs (2014) 0.76
Gender effects on plasma and brain copper. Int J Alzheimers Dis (2011) 0.76
Cognitive Skills and the Aging Brain: What to Expect. Cerebrum (2015) 0.75
Using the Guttman scale to define and estimate measurement error in items over time: the case of cognitive decline and the meaning of "points lost". PLoS One (2012) 0.75
A simple method to rule out dementia with temporal orientation. Alzheimers Dement (2007) 0.75
Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects. Neurobiol Aging (2013) 0.75
Response to Letter to the Editor by Doniger. Resuscitation (2009) 0.75